Product Search |
|
| Input Product Name Or Cas No. |
Category |
Products |
4-Bromo-2-iodopyrimidine |
1-[(3-Fluoro-2-pyridinyl)methyl]-1H-1,2, |
5-(1-Fluorocyclopropyl)-N-methyl-1H-pyra |
5-(1-Fluorocyclopropyl)-1H-pyrazol-3-ami |
1,4,5,7-Tetrahydro-7,7-dimethylpyrano[3, |
1,4-Dimethyl 2-[[4-(diethoxymethylsilyl) |
1,4-Dimethyl 2-[[4-(dimethoxymethylsilyl |
1,4-Dimethyl 2-[(1-oxo-3-buten-1-yl)amin |
Ethyl 5-(triethoxysilyl)-2-(2,2,2-triflu |
3-[3-(Ethoxydimethylsilyl)propyl]dihydro |
ethyl 2-(2,2,2-trifluoroacetyl)pent-4-en |
di-tert-butyl 2-allylmalonate |
3-(3-Triethoxysilylpropyl)-2,4-pentanedi |
Sulfonium, [2-(4-methoxy-1-naphthalenyl) |
5,5′-(2,2′,3,3′,5,5′-Hexamethyl[ |
5-(Chloromethyl)bicyclo[2.2.1]hept-2-ene |
4,5-Dihydronaphtho[1,2-c]furan-1,3-dione |
Bicyclo[2.2.1]hept-5-ene-2-acetic acid |
1,1′-[1,4-Cyclohexanediylbis(methylene |
3a,4,7,7a-Tetrahydro-8-methyl-4,7-methan |
5-(3-Buten-1-yl)bicyclo[2.2.1]hept-2-ene |
Bicyclo[2.2.1]hept-5-ene-2-methanol, 2-( |
5-[[2-(2-Methoxyethoxy)ethoxy]methyl]bic |
5-(Trimethylsilyl)bicyclo[2.2.1]hept-2-e |
5-(5-Hexen-1-yl)bicyclo[2.2.1]hept-2-ene |
2-Bicyclo[2.2.1]hept-5-en-2-yloxirane |
Ethyl bicyclo[2.2.1]hept-5-ene-2-propano |
Ethanol, 2-(2-propen-1-yloxy)-, 1-acetat |
Bicyclo[2.2.1]hept-5-en-2-ylmethyl 3-phe |
1-(Bicyclo[2.2.1]hept-5-en-2-ylmethyl)-1 |
Bicyclo[2.2.1]hept-5-ene-2-propanoic aci |
Bicyclo[2.2.1]hept-2-ene, 5-(trifluorome |
Bicyclo[2.2.1]hept-5-ene-2-ethanamine |
Bicyclo[2.2.1]hept-5-ene-2-acetonitrile |
1,1′-(1,6-Hexanediyl)bis[3,4-dimethyl- |
5-[(2,3,4,5,6-Pentafluorophenyl)methyl]b |
Bicyclo[2.2.1]hept-5-ene-2-butanamine |
7-(Bicyclo[2.2.1]hept-5-en-2-ylmethoxy)- |
Bicyclo[2.2.1]hept-5-ene-2-butanoic acid |
3,4-Dimethyl-1-[3-(triethoxysilyl)propyl |
Bicyclo[2.2.1]hept-5-ene-2-ethanol, 2-me |
1,1-Dimethylethyl N-(bicyclo[2.2.1]hept- |
Bicyclo[2.2.1]hept-5-ene-2-ethanol, 2-(4 |
bicyclo[2.2.1]hept-5-en-2-ylmethyl trifl |
3,4-Dimethyl-1-[6-(triethoxysilyl)hexyl] |
diphenyliodonium 1,1-difluoro-2-oxo-2-(( |
5-(4-methoxy-3,5-dimethylphenyl)-5H-dibe |
5-(4-methoxy-3,5-dimethylphenyl)-5H-dibe |
1-(4-(tert-butyl)phenyl)hexahydrothiopyr |
2,2′-Dibromo-4,4′-dimethoxy-1,1′-b |
|
Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| NX58763 | Ibutilide Fumarate | 122647-32-9 | 95% |
| NX58764 | Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate | 769195-26-8 | 95% |
| NX58765 | 4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide | 404844-11-7 | 95% |
| NX58766 | 5-Bromo-4-chloro-2-(methylthio)pyrimidine | 63810-78-6 | 95% |
| NX58767 | MK-0752 | 952578-68-6 | 95% |
| NX58768 | NVP-LDE 225 | 956697-53-3 | 95% |
| NX58769 | BMS 599626 HCL | 873837-23-1 | 95% |
| NX58770 | BMS 599626 | 714971-09-2 | 95% |
| NX58771 | VCH-759 | 1001913-13-8 | 95% |
| NX58772 | VCH 916 | 1200133-34-1 | 95% |
| NX58773 | BMS 777607 | 1196681-44-3 | 95% |
| NX58774 | GSK 2126458 | 1086062-66-9 | 95% |
| NX58775 | VX-222 | 1026785-59-0 | 95% |
| NX58776 | 2-Hydroxy-6-(trifluoromethyl)pyrimidine-5-carboxylic acid | 154934-95-9 | 95% |
| NX58777 | TG101209 | 936091-14-4 | 95% |
| NX58778 | 5-chloro-N2,N2-dimethyl-2,4-Quinazolinediamine | 494763-17-6 | 95% |
| NX58779 | 4-[(1-methylethyl)amino]-3-nitroBenzonitrile | 355022-17-2 | 95% |
| NX58780 | 4-(1-hexyn-1-yl)Benzaldehyde | 175203-90-4 | 95% |
| NX58781 | 2-bromo-1-(2,6-dimethoxyphenyl)Ethanone | 123184-19-0 | 95% |
| NX58782 | 2-ethynyl-1,4-dimethylBenzene | 74331-70-7 | 95% |
| NX58783 | 1-ethynyl-4-methoxy-2-methylBenzene | 74331-69-4 | 95% |
| NX58784 | 1-[4-(2-chloroethyl)phenyl]Ethanone | 69614-95-5 | 95% |
| NX58785 | Methyl 2,5-dihydroxycinnamate | 63177-57-1 | 95% |
| NX58786 | 4-propylBenzonitrile | 60484-66-4 | 95% |
| NX58787 | 1-[4-(acetyloxy)-2-hydroxyphenyl]Ethanone | 42059-48-3 | 95% |
| NX58788 | 2,5-Dibromo-3-isopropyl-6-methylbenzoquinone | 29096-93-3 | 95% |
| NX58789 | Ethyl 2,4-dichlorophenoxyacetate | 533-23-3 | 95% |
| NX58790 | N-[4-(2-chloroacetyl)phenyl]Acetamide | 140-49-8 | 95% |
| NX58791 | 4-formyl-1,3-Benzenedisulfonic acid | 88-39-1 | 95% |
| NX58792 | Danoprevir | 850876-88-9 | 95% |
|
|
|
|